HomeCompareWXXWY vs NNN

WXXWY vs NNN: Dividend Comparison 2026

WXXWY yields 22.47% · NNN yields 5.66%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 WXXWY wins by $59.4K in total portfolio value
10 years
WXXWY
WXXWY
● Live price
22.47%
Share price
$8.90
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$84.9K
Annual income
$8,701.95
Full WXXWY calculator →
NNN
NNN REIT Inc.
● Live price
5.66%
Share price
$42.03
Annual div
$2.38
5Y div CAGR
8.6%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$25.5K
Annual income
$2,622.67
Full NNN calculator →

Portfolio growth — WXXWY vs NNN

📍 WXXWY pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodWXXWYNNN
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, WXXWY + NNN cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
WXXWY pays
NNN pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

WXXWY
Annual income on $10K today (after 15% tax)
$1,910.11/yr
After 10yr DRIP, annual income (after tax)
$7,396.66/yr
NNN
Annual income on $10K today (after 15% tax)
$481.32/yr
After 10yr DRIP, annual income (after tax)
$2,229.27/yr
At 15% tax rate, WXXWY beats the other by $5,167.39/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of WXXWY + NNN for your $10,000?

WXXWY: 50%NNN: 50%
100% NNN50/50100% WXXWY
Portfolio after 10yr
$55.2K
Annual income
$5,662.31/yr
Blended yield
10.26%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on NNN right now

WXXWY
Analyst Ratings
2
Buy
Consensus: Buy
Altman Z
8.1
Piotroski
8/9
NNN
Analyst Ratings
10
Buy
15
Hold
4
Sell
Consensus: Hold
Price Target
$44.93
+6.9% upside vs current
Range: $43.00 — $48.50
Altman Z
1.1
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

WXXWY buys
0
NNN buys
2
PoliticianChamberTickerTypeAmountDate
Lisa McClain🏢 House$NNN▼ Sell$1,001 - $15,0002025-08-13
Lisa McClain🏢 House$NNN▲ Buy$1,001 - $15,0002025-06-17
Zoe Lofgren🏢 House$NNN▼ Sell$1,001 - $15,0002023-05-25
Ro Khanna🏢 House$NNN▼ Sell$1,001 - $15,0002022-01-20
Zoe Lofgren🏢 House$NNN▲ Buy$1,001 - $15,0002021-09-30
Zoe Lofgren🏢 House$NNN▼ Sell$1,001 - $15,0002020-03-23
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricWXXWYNNN
Forward yield22.47%5.66%
Annual dividend / share$2.00$2.38
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%8.6%
Portfolio after 10y$84.9K$25.5K
Annual income after 10y$8,701.95$2,622.67
Total dividends collected$51.1K$13.7K
Payment frequencyquarterlyquarterly
SectorStockREIT
Analyst consensusBuyHold

Year-by-year: WXXWY vs NNN ($10,000, DRIP)

YearWXXWY PortfolioWXXWY Income/yrNNN PortfolioNNN Income/yrGap
1← crossover$12,947$2,247.19$10,735$614.96+$2.2KWXXWY
2$16,573$2,719.14$11,572$708.43+$5.0KWXXWY
3$20,986$3,252.85$12,531$819.53+$8.5KWXXWY
4$26,304$3,849.55$13,633$952.29+$12.7KWXXWY
5$32,655$4,509.50$14,909$1,111.84+$17.7KWXXWY
6$40,173$5,232.02$16,392$1,304.77+$23.8KWXXWY
7$49,000$6,015.46$18,129$1,539.52+$30.9KWXXWY
8$59,288$6,857.29$20,173$1,827.08+$39.1KWXXWY
9$71,192$7,754.14$22,597$2,181.81+$48.6KWXXWY
10$84,877$8,701.95$25,491$2,622.67+$59.4KWXXWY

WXXWY vs NNN: Complete Analysis 2026

WXXWYStock

WuXi Biologics (Cayman) Inc. provides end-to-end solutions and services for biologics discovery, development and manufacturing in the People's Republic of China, North America, Europe, and internationally. The company also engages in the provision of consultation services in relation to the biopharmaceutical technology, international sales contracting services, testing and development of testing technologies, sales and marketing services, and biologics clinical and manufacturing services; production and sale of medicals; vaccine CDMO and related business; and material supplier activities. WuXi Biologics (Cayman) Inc. has strategic partnership with ImmuneOncia Therapeutics, Legochem Biosciences Inc, Worg Pharma, OncoC4, and Exelixis Inc. The company was incorporated in 2014 and is headquartered in Wuxi, China.

Full WXXWY Calculator →

NNNREIT

National Retail Properties invests primarily in high-quality retail properties subject generally to long-term, net leases. As of September 30, 2020, the company owned 3,114 properties in 48 states with a gross leasable area of approximately 32.4 million square feet and with a weighted average remaining lease term of 10.7 years.

Full NNN Calculator →
📬

Get this WXXWY vs NNN comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

WXXWY vs SCHDWXXWY vs JEPIWXXWY vs OWXXWY vs KOWXXWY vs MAINWXXWY vs ADCWXXWY vs EPRTWXXWY vs FCPT

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.